Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 43.

Frohlich, G M; Keller, P; Schmid, F; Wolfrum, M; Osranek, M; Falk, C; Noll, G; Enseleit, F; Reinthaler, M; Meier, P; Luscher, T F; Ruschitzka, F; Tanner, F C (2013). Haemodynamically irrelevant pericardial effusion is associated with increased mortality in patients with chronic heart failure. European Heart Journal, 34(19):1414-1423.

Breitenstein, A; Sluka, S H; Akhmedov, A; Stivala, S; Steffel, J; Camici, G G; Riem, H H; Beer, H J; Studt, J D; Duru, F; Luscher, T F; Tanner, F C (2012). Dronedarone reduces arterial thrombus formation. Basic Research in Cardiology, 107(6):302.

Bonetti, N R; Namdar, M; Günthard, H F; Gruner, C; Greutmann, M; Steffel, J; Hürlimann, D; Ruef, C; Tanner, F C; Jenni, R; Biaggi, P (2012). Early versus late initial echocardiographic assessment in infective endocarditis: similar findings and no difference in clinical outcome. Cardiovascular Medicine, 15(11):317-324.

Holy, E W; Forestier, M; Richter, E K; Akhmedov, A; Leiber, F; Camici, G G; Mocharla, P; Lüscher, T F; Beer, J H; Tanner, F C (2011). Dietary α-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(8):1772-1180.

Fauchère, I; Jenni, R; Tanner, F C (2011). Triple heart image: one heart beats as three. European Journal of Echocardiography, 12(8):639.

Breitenstein, A; Stein, S; Holy, E W; Camici, G G; Lohmann, C; Akhmedov, A; Spescha, R; Elliott, P J; Westphal, C H; Matter, C M; Lüscher, T F; Tanner, F C (2011). Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovascular Research, 89(2):464-472.

Haegeli, L M; Ercin, E; Wolber, T; Brunckhorst, C; Tanner, F C; Jenni, R; Lüscher, T F; Duru, F (2011). Arrhythmic manifestations in patients with congenital left ventricular aneurysms and diverticula. American Journal of Cardiology, 108(12):1826-1830.

Rozenberg, I; Sluka, S H M; Mocharla, P; Hallenberg, A; Rotzius, P; Borén, J; Kränkel, N; Landmesser, U; Borsig, L; Lüscher, T F; Eriksson, E E; Tanner, F C (2011). Deletion of L-selectin increases atherosclerosis development in ApoE-/- mice. PLoS ONE, 6(7):e21675.

Besler, C; Heinrich, K; Rohrer, L; Doerries, C; Riwanto, M; Shih, D M; Chroni, A; Yonekawa, K; Stein, S; Schaefer, N; Mueller, M; Akhmedov, A; Daniil, G; Manes, C; Templin, C; Wyss, C; Maier, W; Tanner, F C; Matter, C M; Corti, R; Furlong, C; Lusis, A J; von Eckardstein, Arnold; Fogelman, A M; Lüscher, T F; Landmesser, U (2011). Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. Journal of Clinical Investigation, 121(7):2693-708.

Gebhard, C; Stähli, B E; Shi, Y; Camici, G G; Akhmedov, A; Hoegger, L; Lohmann, C; Matter, C M; Hassa, P O; Hottiger, M O; Malinski, T; Lüscher, T F; Tanner, F C (2011). Poly(ADP-ribose) polymerase-1 protects from oxidative stress induced endothelial dysfunction. Biochemical and Biophysical Research Communications (BBRC), 414(4):641-646.

Stähli, B E; Bünzli, R; Grünenfelder, J; Bühler, I; Felix, C; Bettex, D; Biaggi, P; Tanner, F C; Nguyen-Kim, D L; Plass, A; Ge, H; Falk, V; Lüscher, T F; Corti, R; Maier, W; Altwegg, L A (2011). Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the valve academic research consortium (VARC). Journal of Invasive Cardiology, 23(8):307-312.

Zuercher, J; Neidhardt, J; Magyar, I; Labs, S; Moore, A; Tanner, F C; Waseem, N; Schorderet, D F; Munier, F L; Bhattacharya, S; Berger, W; Kloeckener-Gruissem, B (2010). Alterations of the 5'untranslated region of SLC16A12 lead to age-related cataract. Investigative Ophthalmology and Visual Science, 51(7):3354-3361.

Holy, E W; Stämpfli, S F; Akhmedov, A; Holm, N; Camici, G G; Lüscher, T F; Tanner, F C (2010). Laminin receptor activation inhibits endothelial tissue factor expression. Journal of Molecular and Cellular Cardiology, 48(6):1138-1145.

Gebhard, C; Breitenstein, A; Akhmedov, A; Gebhard, C E; Camici, G G; Lüscher, T F; Tanner, F C (2010). Amphetamines induce tissue factor and impair tissue factor pathway inhibitor: role of dopamine receptor type 4. European Heart Journal, 31(14):1780-1791.

Stämpfli, S F; Akhmedov, A; Gebhard, C; Lohmann, C; Holy, E W; Rozenberg, I; Spescha, R; Shi, Y; Lüscher, T F; Tanner, F C; Camici, G G (2010). Aging induces endothelial dysfunction while sparing arterial thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(10):1960-1967.

Asmis, L; Tanner, F C; Sudano, I; Lüscher, T F; Camici, G G (2010). DMSO inhibits human platelet activation through cyclooxygenase-1 inhibition. A novel agent for drug eluting stents? Biochemical and Biophysical Research Communications (BBRC), 391(4):1629-16333.

Rozenberg, I; Sluka, S H M; Rohrer, L; Hofmann, J; Becher, B; Akhmedov, A; Soliz, J; Mocharla, P; Borén, J; Johansen, P; Steffel, J; Watanabe, T; Lüscher, T F; Tanner, F C (2010). Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(5):923-930.

Camici, G G; Steffel, J; Amanovic, I; Breitenstein, A; Baldinger, J; Keller, S; Lüscher, T F; Tanner, F C (2010). Rapamycin promotes arterial thrombosis in vivo: implications for everolimus and zotarolimus eluting stents. European Heart Journal, 31(2):236-242.

Stein, S; Schäfer, N; Breitenstein, A; Besler, C; Winnik, S; Lohmann, C; Heinrich, K; Brokopp, C E; Handschin, C; Landmesser, U; Tanner, F C; Lüscher, T F; Matter, C M (2010). SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging, 2(6):353-360.

Toggweiler, S; Turina, J; Jenni, R; Tanner, F C (2010). Spontaneous regression of severe traumatic tricuspid valve regurgitation. European Heart Journal, 31(5):560.

Breitenstein, A; Tanner, F C; Lüscher, T F (2010). Tissue factor and cardiovascular disease:Quo Vadis? Circulation Journal, 74(1):3-12.

Holy, E W; Tanner, F C (2010). Tissue factor in cardiovascular disease pathophysiology and pharmacological intervention. Advances in Pharmacology, 59:259-292.

Gebhard, C; Akhmedov, A; Mocharla, P; Angstenberger, J; Sahbai, S; Camici, G G; Lüscher, T F; Tanner, F C (2009). PDGF-CC induces tissue factor expression: role of PDGF receptor alpha/beta. Basic Research in Cardiology, 105(3):349-356.

Gebhard, C; Stämpfli, S F; Gebhard, C E; Akhmedov, A; Breitenstein, A; Camici, G G; Holy, E W; Lüscher, T W; Tanner, F C (2009). Guggulsterone, an anti-inflammatory phytosterol, inhibits tissue factor and arterial thrombosis. Basic Research in Cardiology, 104(3):285-294.

Camici, G G; Sudano, I; Noll, G; Tanner, F C; Lüscher, T F (2009). Molecular pathways of aging and hypertension. Current Opinion in Nephrology and Hypertension, 18(2):134-137.

Holy, E W; Akhmedov, A; Lüscher, T L; Tanner, F C (2009). Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. Journal of Molecular and Cellular Cardiology, 46(2):234-240.

Stähli, B E; Camici, G G; Tanner, F C (2009). Drug-eluting stent thrombosis. Therapeutic Advances in Cardiovascular Disease, 3(1):45-52.

Breitenstein, A; Camici, G G; Tanner, F C (2009). Tissue factor: beyond coagulation in the cardiovascular system. Clinical Science, 118(3):159-172.

Breitenstein, A; Stämpfli, S F; Camici, G G; Akhmedov, H R; Ha, H R; Follath, F; Bogdanova, A; Lüscher, T F; Tanner, F C (2008). Amiodarone inhibits arterial thrombus formation and tissue factor translation. Arteriosclerosis Thrombosis and Vascular Biology, 28(12):2231-2238.

Camici, G G; Cosentino, C; Tanner, F C; Lüscher, T F (2008). The role of p66Shc deletion in age-associated arterial dysfunction and disease states. Journal of Applied Physiology, 105(5):1628-1631.

Largiadèr, T; Masato, E; Payeli, S K; Greutert, H; Viswambharan, H; Lachat, Mario L; Zünd, G; Yang, Z; Tanner, F C; Lüscher, T F (2008). Endothelial nitric oxide synthase gene transfer inhibits human smooth muscle cell migration via inhibition of Rho A. Journal of Cardiovascular Pharmacology, 52(4):369-374.

Payeli, S K; Latini, R; Gebhard, K; Patrignani, A; Wagner, U; Lüscher, T F; Tanner, F C (2008). Prothrombotic gene expression profile in vascular smooth muscle cells of human saphenous vein, but not internal mammary artery. Arteriosclerosis, Thrombosis and Vascular Biology, 28(4):705-710.

Payeli, S K; Schiene-Fischer, C; Steffel, J; Camic, G G; Rozenberg, I; Lüscher, T F; Tanner, F C (2008). Cyclophilin A differentially activates monocytes and endothelial cells Role of purity, activity, and endotoxin contamination in commercial preparations. Atherosclerosis, 197(2):564-571.

von Lukowicz, T; Hassa, P O; Lohmann, C; Borén, J; Braunersreuther, V; Mach, F; Odermatt, B; Gersbach, M; Camici, G G; Stähli, B E; Tanner, F C; Hottiger, M O; Lüscher, T F; Matter, C M (2008). PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovascular Research, 78(1):158-166.

Stämpfli, S F; Asmis, L M; Tanner, F C (2008). Wirkungsweise alter und neuer Antikoagulanzien. Herz, 33:4-12.

Stähli, B E; Breitenstein, A; Akhmedov, A; Camici, G G; Shojaati, K; Bogdanov, N; Steffel, J; Ringli, D; Lüscher, T F; Tanner, F C (2007). Cardiac glycosides regulate endothelial tissue factor expression in culture. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(12):2769-2776.

Tanner, F C; van der Loo, B; Shaw, S; Greutert, H; Bachschmid, M M; Berrozpe, M; Rozenberg, I; Blau, N; Siebenmann, R; Schmidli, J; Meyer, P; Lüscher, T F (2007). Inactivity of nitric oxide synthase gene in the atherosclerotic human carotid artery. Basic Research in Cardiology, 102(4):308-317.

Lüscher, T F; Steffel, J; Eberli, F R; Joner, M; Nakazawa, G; Tanner, F C; Virmani, R (2007). Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation, 115(8):1051-1058.

Steffel, J; Lüscher, T F; Tanner, F C (2006). Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation, 113(5):722-731.

Steffel, J; Luscher, T F; Ruschitzka, F; Tanner, F C (2006). Cyclooxygenase-2 inhibition and coagulation. Journal of Cardiovascular Pharmacology, 47 Sup:S15-20.

Steffel, J; Akhmedov, A; Fahndrich, C; Ruschitzka, F; Luscher, T F; Tanner, F C (2006). Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells. Biochemical and Biophysical Research Communications (BBRC), 349(2):597-603.

Tanner, F C; Hegglin, Daniel; Thoma, R; Brosi, G; Deplazes, P (2006). Echinococcus multilocularis in Graubünden: Verbreitung bei Füchsen und Vorkommen potentieller Zwischenwirte. Schweizer Archiv für Tierheilkunde, 148(9):501-510.

Steffel, J; Hermann, M; Greutert, H; Gay, S; Lüscher, T F; Ruschitzka, F; Tanner, F C (2005). Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation, 111(13):1685-1689.

This list was generated on Fri Nov 24 23:04:58 2017 CET.